Se Jun Park
Overview
Explore the profile of Se Jun Park including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
332
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Park S, Shin K, Kim I, Lee M, Hong T, Kim H
Sci Rep
. 2025 Jan;
15(1):3386.
PMID: 39870720
Advanced hepatocellular carcinoma (HCC) poses treatment challenges, especially where access to multi-kinase inhibitors and ICIs is limited by high costs and lack of insurance. This study evaluates the effectiveness of...
2.
Park G, Park S, Kim Y
Front Oncol
. 2024 Dec;
14:1453906.
PMID: 39634269
Objective: Claudin18.2 has been established as a putative therapeutic target in human solid malignancies. The aim of this study is to determine claudin18.2 expression as a clinicopathological and prognostic factor...
3.
Park S, Shin K, Hong T, Lee S, Kim I, Kim Y, et al.
Cancers (Basel)
. 2024 Aug;
16(15).
PMID: 39123483
Adenocarcinoma of the ampulla of Vater (AAC) is a rare malignancy with heterogeneous tumors arising from various histologic subtypes, necessitating new therapeutic strategies. This study examines epidermal growth factor receptor...
4.
Lee S, Park S, Shin K, Hong T, Kim I, Lee M
BMC Cancer
. 2024 May;
24(1):634.
PMID: 38783256
Background: Adenocarcinoma of the ampulla of Vater (AoV) is one of the rare periampullary cancers, and due to its anatomical location, it is categorized into various histologic subtypes. Its rarity...
5.
Park S, Park J, Shin K, Hong T, Kim Y, Kim I, et al.
Biomedicines
. 2024 Apr;
12(4).
PMID: 38672257
Pancreatic ductal adenocarcinoma (PDAC) is notorious for its aggressive progression and dismal survival rates, with this study highlighting elevated interleukin 6 (IL-6) levels in patients as a key marker of...
6.
Park S, Shin K, Hong T, Lee S, Kim I, Kim Y, et al.
Sci Rep
. 2023 Oct;
13(1):16547.
PMID: 37783755
Patients with ampulla of Vater adenocarcinoma exhibit diverse outcomes, likely since these malignancies can originate from any of the three converging epithelia at this site. Such variability presents difficulties in...
7.
Shin K, Kim J, Park S, Kim H, Lee M, Kim O, et al.
Cancers (Basel)
. 2023 Aug;
15(15).
PMID: 37568771
The clinical significance of PD-1 expression in circulating CD8 T cells in patients with gastric cancer (GC) receiving chemotherapy remains unelucidated. Therefore, we aimed to examine its prognostic significance in...
8.
Park S, Park J, Shin K, Hong T, Lee M, Kim Y, et al.
BMC Cancer
. 2023 May;
23(1):389.
PMID: 37127565
Background: Interactions between the programmed cell death receptor 1 (PD-1) and its ligand (PD-L1) lead to immune evasion in various tumors and are associated with poor prognosis in patients with...
9.
Park S, Shin K, Kim I, Hong T, Kim Y, Lee M
World J Gastrointest Oncol
. 2023 May;
15(4):677-688.
PMID: 37123060
Background: Owing to rarity of disease and lack of prospective studies, data supporting the role of adjuvant chemotherapy in ampulla of Vater (AoV) carcinoma is limited. Aim: To evaluate whether...
10.
Shin K, Kim J, Park S, Lee M, Park J, Choi M, et al.
Sci Rep
. 2023 Apr;
13(1):6952.
PMID: 37117200
The prognostic role of soluble PD-L1 (sPD-L1) and exosomal PD-L1 (exoPD-L1) in patients with gastric cancer (GC) receiving systemic chemotherapy remains unelucidated. Thus, we examined their prognostic significance in patients...